Evidence map›Paper›PMID 21254218›Full record

ArticleGenetic epidemiology2011

Mining gold dust under the genome wide significance level: a two-stage approach to analysis of GWAS.

Gang Shi, Eric Boerwinkle, Alanna C Morrison, C Charles Gu, Aravinda Chakravarti, D C Rao

Open access · bronzeAbstract read
In one paragraph

Article in Genetic epidemiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Author's reply to "A novel seven-gene panel predicts the sensitivity and prognosis of head and neck squamous cell carcinoma treated with platinum-based radio(chemo)therapy".European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2021
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gang ShiDivision of Biostatistics, Washington University School of Medicine, Saint Louis, Missouri 63110-1093, USA. gang@wubios.wustl.edu
Eric Boerwinkle
Alanna C Morrison
C Charles Gu
Aravinda Chakravarti
D C Rao
Washington University in St. Louis · USThe University of Texas Health Science Center at Houston · USJohns Hopkins University · US

Funding

Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
The Family Blood Pressure Program (Program Data Center)U01HL054473 · NHLBI · WASHINGTON UNIVERSITY · PI RAO, DABEERU C · 2000 to 2008
$5.8M
RESEARCH PROJECT IN GENETIC EPIDEMIOLOGYR01GM028719 · NIGMS · WASHINGTON UNIVERSITY · PI RAO, DABEERU C · 1985 to 2008
$2.0M
NHLBI NIH HHS 5R01HL086694NHLBI NIH HHS 5U01HL054473NHLBI NIH HHS R01 HL086694NHLBI NIH HHS U01 HL054473NIGMS NIH HHS 5R01GM028719NIGMS NIH HHS R01 GM028719
6 · The paper itself

Abstract

We propose a two-stage approach to analyze genome-wide association data in order to identify a set of promising single-nucleotide polymorphisms (SNPs). In stage one, we select a list of top signals from single SNP analyses by controlling false discovery rate. In stage two, we use the least absolute shrinkage and selection operator (LASSO) regression to reduce false positives. The proposed approach was evaluated using simulated quantitative traits based on genome-wide SNP data on 8,861 Caucasian individuals from the Atherosclerosis Risk in Communities (ARIC) Study. Our first stage, targeted at controlling false negatives, yields better power than using Bonferroni-corrected significance level. The LASSO regression reduces the number of significant SNPs in stage two: it reduces false-positive SNPs and it reduces true-positive SNPs also at simulated causal loci due to linkage disequilibrium. Interestingly, the LASSO regression preserves the power from stage one, i.e., the number of causal loci detected from the LASSO regression in stage two is almost the same as in stage one, while reducing false positives further. Real data on systolic blood pressure in the ARIC study was analyzed using our two-stage approach which identified two significant SNPs, one of which was reported to be genome-significant in a meta-analysis containing a much larger sample size. On the other hand, a single SNP association scan did not yield any significant results.

Indexed as

Genome-Wide Association StudyPolymorphism, Single NucleotideComputer SimulationFalse Negative ReactionsFalse Positive ReactionsHumansLinkage DisequilibriumModels, StatisticalMolecular EpidemiologyRegression AnalysisReproducibility of Results

Identifiers

PMID21254218
PMCPMC3624896
OpenAlexW2114314276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.